Czechia· CZ-0271586
HEMGENIX
A etranacogene dezaparvovec product containing etranacogene dezaparvovec, registered in Czechia by CSL Behring GmbH, Marburg. The same ATC class is registered in 10 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Etranacogene dezaparvovec is registered in 10 of 19 countries.
Countries holding a registration under ATC B02BD16 (etranacogene dezaparvovec), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Etranacogene dezaparvovec · ATC B02BD16
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ETRANACOGENE DEZAPARVOVEC
- Manufacturer
- CSL Behring GmbH, Marburg
- Country
- Czechia (CZ)
- ATC code
- B02BD16
- ATC class
- Etranacogene dezaparvovec
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etranacogene dezaparvovec in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandHemgenix
- SpainHEMGENIX 1x10E13 COPIAS DEL GENOMA/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONCsl Behring Gmbh
- FinlandHemgenixCSL Behring GmbH
- FranceHEMGENIX 1 x 10 000 000 000 000 copies du génome/mL, solution à diluer pour perfusionCSL BEHRING (ALLEMAGNE)
- United KingdomHemgenix 100 tera genome copies/10ml concentrate for solution for infusion vialsCSL Behring UK Ltd
- IrelandHemgenix 1 x 10^13 genome copies/mL concentrate for solution for infusionCSL Behring GmbH
- IcelandHemgenixCSL Behring GmbH*
- NetherlandsHemgenix 1x10E13 genoomkopieën/ml concentraat voor oplossing voor infusieCSL Behring GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Hemgenix
- Liechtenstein · Hemgenix
- Norway · Hemgenix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc73c1ba-552d-49e0-a10e-4e75fa4bcec4 GET /v1/drugs/dc73c1ba-552d-49e0-a10e-4e75fa4bcec4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INF CNC SOL",
"source": "sukl",
"strength": "1X10^13GC/ML",
"pack_size": "(1-X)X10ML",
"substance": "ETRANACOGENE DEZAPARVOVEC",
"cz_kod_sukl": "0271586",
"product_type": "AD/GM",
"substance_codes": "22116",
"registration_state": "R",
"registration_number": "EU/1/22/1715/001"
}See everything about etranacogene dezaparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.